We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$2.51B
AUM Growth
+$1.17B
Cap. Flow
+$1.14B
Cap. Flow %
45.4%
Top 10 Hldgs %
46.36%
Holding
1,466
New
813
Increased
130
Reduced
121
Closed
402

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$114M
2
IQ icon
iQIYI
IQ
+$19.6M
3
AER icon
AerCap
AER
+$18.3M
4
PEG icon
Public Service Enterprise Group
PEG
+$12.5M
5
HHH icon
Howard Hughes
HHH
+$12.3M

Sector Composition

Rank Sector Weight
1 Utilities 13.39%
2 Technology 9.99%
3 Consumer Discretionary 6.99%
4 Industrials 6.47%
5 Consumer Staples 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBCP icon
1101
Concrete Pumping Holdings
BBCP
$470M
-15,308
Closed -$137K
BFC icon
1102
Bank First Corp
BFC
$1.69B
-6,704
Closed -$395K
BH icon
1103
Biglari Holdings Class B
BH
$1.24B
-1,800
Closed -$254K
BIDU icon
1104
Baidu
BIDU
$31.6B
-1,966
Closed -$324K
BNY
1105
Bank of New York Mellon
BNY
$108B
-5,652
Closed -$285K
BLFS icon
1106
BioLife Solutions
BLFS
$1.81B
-24,987
Closed -$447K
BMA icon
1107
Banco Macro
BMA
$4.66B
-70,083
Closed -$3.21M
BN icon
1108
Brookfield
BN
$93.1B
-67,125
Closed -$1.12M
BMY icon
1109
Bristol-Myers Squibb
BMY
$137B
-75,294
Closed -$3.51M
BRC icon
1110
Brady Corp
BRC
$4.3B
-5,785
Closed -$268K
BRK.B icon
1111
Berkshire Hathaway Class B
BRK.B
$1.06T
-12,041
Closed -$2.42M
BRKR icon
1112
Bruker
BRKR
$9.07B
-23,800
Closed -$915K
BSAC icon
1113
Banco Santander Chile
BSAC
$16.6B
-13,959
Closed -$415K
BTI icon
1114
British American Tobacco
BTI
$121B
-10,192
Closed -$425K
BUSE icon
1115
First Busey Corp
BUSE
$2.5B
-20,937
Closed -$511K
CASH icon
1116
Pathward Financial
CASH
$1.74B
-12,459
Closed -$245K
CASY icon
1117
Casey's General Stores
CASY
$30.9B
-3,962
Closed -$510K
CBRE icon
1118
CBRE Group
CBRE
$44B
-5,637
Closed -$279K
CBSH icon
1119
Commerce Bancshares
CBSH
$8.37B
-52,631
Closed -$2.17M
CCRD
1120
DELISTED
CoreCard
CCRD
-11,414
Closed -$365K
CDLX icon
1121
Cardlytics
CDLX
$25.3M
-1,119
Closed -$185K
CEPU
1122
Central Puerto
CEPU
$1.95B
-86,358
Closed -$794K
CGBD icon
1123
Carlyle Secured Lending
CGBD
$781M
-11,600
Closed -$168K
CHRW icon
1124
C.H. Robinson
CHRW
$16.5B
-10,044
Closed -$874K
CKPT
1125
DELISTED
Checkpoint Therapeutics
CKPT
-3,542
Closed -$101K

Similar funds

Michael Gelband's Q2 2019 Portfolio in Review

As of Q2 2019, Michael Gelband held 1,466 positions worth $2.51B, up 87% from $1.34B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Michael Gelband deployed $1.14B of net new capital in Q2 2019, opening 813 new positions and adding to 130 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 260,259 shares worth $76.3M.

By sector, the portfolio is most concentrated in Utilities at 13% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Altaba Inc, an estimated $114M trimmed.

  • Michael Gelband's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 260,259 shares worth $76.3M.
  • Michael Gelband added most to Aramark in Q2 2019, an estimated $58.3M increase.
  • Michael Gelband's biggest Q2 2019 reduction was Altaba Inc, cutting an estimated $114M.
  • Michael Gelband fully exited AerCap in Q2 2019, selling an estimated $18.3M.
  • Michael Gelband's ten largest holdings make up 46% of its $2.51B portfolio in Q2 2019.
  • Michael Gelband opened 813 new positions and closed 402 in Q2 2019.
  • Michael Gelband's portfolio value rose 87% quarter-over-quarter to $2.51B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.